Intravitreal Administration of HA-1077, a ROCK Inhibitor, Improves Retinal Function in a Mouse Model of Huntington Disease

• Mei Li,

  Current address: Vision Science Core, Gene Delivery Module, School of Optometry, University of California, Berkeley, California, United States of America

  Affiliation Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, United States of America

  ⨯
• Douglas Yasumura,

  Affiliation Beckman Vision Center, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Aye Aye K. Ma,

  Affiliation Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, United States of America

  ⨯
• Michael T. Matthes,

  Affiliation Beckman Vision Center, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Haidong Yang,

  Affiliation Beckman Vision Center, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Gregory Nielson,

  Affiliation Beckman Vision Center, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Yong Huang,

  Affiliation UCSF School of Pharmacy, Department of Bioengineering and Therapeutic Sciences, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Francis C. Szoka,

  Affiliation Department of Biopharmaceutical Sciences, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Matthew M. LaVail,

  Affiliation Beckman Vision Center, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Marc I. Diamond

  * E-mail: diamondm@neuro.wustl.edu

  Affiliation Department of Neurology, Washington University in St. Louis, St. Louis, Missouri, United States of America

  ⨯